Vertical-Specific
AI For Regulatory Teams
Empowering faster, smarter regulatory decisions for Life Sciences and Consumer Products teams.
Vertical-Specific
What we deliver
RegASK’s AI-Driven regulatory intelligence platform combines agentic AI, vertical LLMs, and a community of 1700+ subject matter experts to deliver triaged regulatory alerts, tailored impact assessments, and end-to-end workflow orchestration.
This improves compliance outcomes, mitigates risks, and accelerates time to market across more than 150+ countries.
Turn regulatory complexity into clarity
on one intelligent, secure platform
Stay on top of latest global regulatory changes
- Curated Alerts
- Over 1700+ subject matter experts
- AI-Driven Insights augmented with expert knowledge
Get tailored, actionable, and timely insights for your business
- Insights Dashboard
- Proactive Risk Identification
- Data-Driven Decision Making
- Horizon Scanning
- Report Generation
Manage compliance risks proactively
- AI-Driven Risk Assessments
- Ask RegASK
- Regulatory Change Impact Analysis
Improve efficiency and simplify operations with a centralized intelligence platform
- Conversational AI Copilot
- Automated Workflows
- Centralized Knowledge Hub
RegASK News
RegASK Unveils Action Hub: Revolutionizing Regulatory A…
RegASK Unveils Action Hub: Revolutionizing Regulatory AI Operations RegASK was recently featured in AI Technology Insights for the launch of…
Read more
RegASK Launches First Vertical Agentic AI Command Cente…
New Action Hub brings specialized AI workflows together in one intelligent workspace, simplifying regulatory operations and boosting product…
Read more
RegASK Launches Agentic AI Architecture for CPG Regulat…
RegASK Launches Agentic AI Architecture for CPG Regulatory Affairs RegASK was recently featured in Supply & Demand Chain Executive for t…
Read more
Case Study: Clinical Research site in UK
Watch how RegASK empowered a UK-based clinical research site to overcome their compliance challenges.
40%
Experienced a significant increase in operational efficiency
50%
Decrease in manual monitoring time
100%
Compliant in clinical trials across multiple regions
Case Study: Japanese Food Industry
Watch how RegASK helped a leading food industry MNC in Japan transform its compliance processes.
50%
Time freed and improvement in operational efficiency
60%
Time reduced in handling regulatory tasks and inquiries
200
Inquiries per week handled with streamlined workflows
The 2025 State of Regulatory Affairs and Compliance Report
Drawing on insights from 145+ industry experts, RegASK’s report outlines key regulatory challenges, the role of AI in compliance, and the risks of falling behind.
38%
of regulatory teams feel at risk of non-compliance.
42%
of teams miss compliance deadlines
73%
of executives call for stricter AI regulations.
What our customers say about us
“What sets RegASK apart is their practical approach that is catered to you, their flexibility to align with your strategy, and the ability to target deep expertise globally. I highly recommend RegASK. They are true partners in navigating the regulatory maze.”
Shiva Kannan
Chief Operations Officer
Fibronostics
“RegASK helped me deep dive into several Asian markets with beauty devices/skincare. This saved me 20+ hours of research and freed me to complete other projects. We had great success in registering our China skincare also. Just wonderful to work with and it is a real partnership!”
Danielle Barker Fernandes
Senior Manager R&D/ R.A.
NuFACE
“We have worked with RegASK on several specific projects which enabled us to clarify internally certain choices we needed to make based on different levels of regulatory risk across countries. This provided an important framework to structure our strategic thinking.”
Béatrice Guelet
International Regulatory Affairs Manager
NAOS
120+
Countries
1700+
Experts
1.2M+
Regulatory Data Points
1000+
Publishers
Resources
U.S. Consumer and Public Health Groups Urge Congress to…
A major policy debate has emerged in the United States over the regulation of food additives. On October 24, 2025, the advocacy group Americ…
Read more
Saudi MOH Reaffirms Safety and Efficacy of Statin Drugs…
The Saudi Ministry of Health (MOH) has issued an official advisory on 15 October 2025 reaffirming the safety and efficacy of statin choleste…
Read more
Finland Proposes Multi-Tiered Soft Drink Tax Reform to …
On September 25, 2025, the Finnish government announced a proposal to amend existing taxation laws, introducing major reforms to the soft dr…
Read more
New FDA Pilot Program that Could Reshape the Future of …
The U.S. Food and Drug Administration (FDA) has announced a pilot prioritization program for Abbreviated New Drug Applications (ANDAs) that …
Read more
FSA Proposes Ban on BPA and Related Compounds in Food P…
The UK Food Standards Agency (FSA) has opened a public consultation proposing a ban on bisphenol A (BPA), other bisphenols, and bisphenol de…
Read more
Global Regulators Confirm No Link Between Paracetamol U…
Between September 23–26, 2025, multiple health authorities, including Singapore’s Health Sciences Authority (HSA), Australia’s Therape…
Read more
U.S. Launches Investigation into Medical Device and PPE…
On September 26, 2025, the U.S. Department of Commerce’s Bureau of Industry and Security (BIS) announced a Section 232 investigation into …
Read more
Regulatory Update on ISO Targets 1,4-Dioxane in Cosmeti…
On 7 August 2025, the International Organization for Standardization (ISO) announced the registration of a new project, ISO/AWI 24913, d…
Read more
How Pharmaceutical Companies Can Use AI to Stay Complia…
According to Deloitte’s 2023 global life sciences outlook, more than 60% of biopharma executives reported that their organizations are…
Read more
Stay in the know.
Optimize workflows.
Regulatory compliance powered by AI.